These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3133335

  • 21. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
    Ito N, Fukushima S, Shirai T, Nakanishi K.
    Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
    [Abstract] [Full Text] [Related]

  • 22. Low susceptibility of Long-Evans Cinnamon rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis and inhibitory effect of urinary copper.
    Chone Y, Kinouchi T, Yamada T, Suzuki Y, Kitaura K, Jiao Z, Minami T, Bando Y, Uehara H, Mochizuki M, Ohnishi Y, Izumi K.
    Jpn J Cancer Res; 2000 Jan; 91(1):16-24. PubMed ID: 10744040
    [Abstract] [Full Text] [Related]

  • 23. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
    Fukushima S, Hagiwara A, Ogiso T, Shibata M, Ito N.
    Food Chem Toxicol; 1983 Feb; 21(1):59-68. PubMed ID: 6681793
    [Abstract] [Full Text] [Related]

  • 24. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.
    Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N.
    Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816
    [Abstract] [Full Text] [Related]

  • 25. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 27. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T, Na Y, Wanibuchi H, Yamamoto S, Lee CC, Fukushima S.
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [Abstract] [Full Text] [Related]

  • 28. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Fukushima S, Kurata Y, Shibata M, Ikawa E, Ito N.
    Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
    [Abstract] [Full Text] [Related]

  • 29. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kurata Y, Asamoto M, Hagiwara A, Masui T, Fukushima S.
    Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
    [Abstract] [Full Text] [Related]

  • 30. Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ito N, Shirai T, Fukushima S, Hirose M.
    J Cancer Res Clin Oncol; 1984 Aug; 108(1):169-73. PubMed ID: 6746710
    [Abstract] [Full Text] [Related]

  • 31. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis.
    Murai T, Mori Y, Tatematsu K, Koide A, Hagiwara A, Makino S, Mori S, Wanibuchi H, Fukushima S.
    Cancer Sci; 2005 Oct; 96(10):637-44. PubMed ID: 16232194
    [Abstract] [Full Text] [Related]

  • 32. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Okajima E, Hiramatsu T, Okamoto M, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Kubota K, Samma S, Okamura K, Kaneko Y, Horii Y, Moriya A.
    Gan To Kagaku Ryoho; 1982 May; 9(5):836-42. PubMed ID: 7184430
    [Abstract] [Full Text] [Related]

  • 33. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
    Okumura M, Shirai T, Asamoto M, Ogiso T, Fukushima S.
    Cancer Lett; 1991 Jun 14; 58(1-2):81-5. PubMed ID: 2049787
    [Abstract] [Full Text] [Related]

  • 34. High susceptibility of an analbuminemic congenic strain of rats with an F344 genetic background to induced bladder cancer and its possible mechanism.
    Takahashi M, Shumiya S, Maekawa A, Hayashi Y, Nagase S.
    Jpn J Cancer Res; 1988 Jun 14; 79(6):705-9. PubMed ID: 3137197
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G, Miyata Y, Babaya K, Arai M, Fukushima S, Ito N.
    Gan; 1980 Jun 14; 71(3):333-40. PubMed ID: 7418979
    [Abstract] [Full Text] [Related]

  • 36. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hirose M, Murasaki G, Imaida K, Fukushima S, Ito N.
    Gan; 1980 Oct 14; 71(5):729-32. PubMed ID: 7227722
    [Abstract] [Full Text] [Related]

  • 37. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M, Suzuki E, Hashimoto Y.
    Gan; 1976 Dec 14; 67(6):825-34. PubMed ID: 191321
    [Abstract] [Full Text] [Related]

  • 38. Lack of enhancing effect of two Kampo medicines, Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on rat urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A, Sano M, Tanaka H, Kawabe M, Tamano S, Kadota T, Yanagisawa T, Maemura S, Ito N, Shirai T.
    Teratog Carcinog Mutagen; 2002 Dec 14; 22(1):41-50. PubMed ID: 11754386
    [Abstract] [Full Text] [Related]

  • 39. Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M, Fukushima S, Okamura T, Sakata T, Ito N, Koiso K, Niijima T.
    Cancer; 1984 Oct 15; 54(8):1525-9. PubMed ID: 6434176
    [Abstract] [Full Text] [Related]

  • 40. Cataracts in rats given a bladder carcinogen, N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Fujita J, Yoshida O, Fujita H, Mikuni I.
    Tokai J Exp Clin Med; 1983 Nov 15; 8(4):359-63. PubMed ID: 6679940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.